BD Buys Sirigen | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson announced today that it has acquired Sirigen, a maker of polymer dyes that are used in flow cytometry and other technologies.

Hampshire, UK-based Sirigen has developed the High Sensitivity Fluorescence detection technology with applications in the diagnostics and life science research markets. The firm's technology is platform agnostic, and according to its website, can facilitate high-volume screening for personalized medicine purposes and can be used to boost the performance of existing molecular diagnostics tests and immunoassays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.